COVID-19 Impact on Global Durvalumab Market Insights, Forecast to 2026
Durvalumab market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Durvalumab market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Durvalumab market is segmented into
The Durvalumab market is analysed and market size information is provided by regions (countries).
The key regions covered in the Durvalumab market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Durvalumab Market Share Analysis
Durvalumab market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Durvalumab business, the date to enter into the Durvalumab market, Durvalumab product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Durvalumab market is segmented into
- 2.4mL Injection
- 10mL Injection
- Locally Advanced Urothelial Carcinoma
- Metastatic Urothelial Carcinoma
- Other
The Durvalumab market is analysed and market size information is provided by regions (countries).
The key regions covered in the Durvalumab market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Durvalumab Market Share Analysis
Durvalumab market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Durvalumab business, the date to enter into the Durvalumab market, Durvalumab product introduction, recent developments, etc.
The major vendors covered:
- Medimmune (AstraZeneca)
1 STUDY COVERAGE
1.1 Durvalumab Product Introduction
1.2 Market Segments
1.3 Key Durvalumab Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Durvalumab Market Size Growth Rate by Type
1.4.2 2.4mL Injection
1.4.3 10mL Injection
1.5 Market by Application
1.5.1 Global Durvalumab Market Size Growth Rate by Application
1.5.2 Locally Advanced Urothelial Carcinoma
1.5.3 Metastatic Urothelial Carcinoma
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Durvalumab Industry Impact
1.6.1 How the Covid-19 is Affecting the Durvalumab Industry
1.6.1.1 Durvalumab Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Durvalumab Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Durvalumab Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Durvalumab Market Size Estimates and Forecasts
2.1.1 Global Durvalumab Revenue 2015-2026
2.1.2 Global Durvalumab Sales 2015-2026
2.2 Durvalumab Market Size by Region: 2020 Versus 2026
2.2.1 Global Durvalumab Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Durvalumab Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL DURVALUMAB COMPETITOR LANDSCAPE BY PLAYERS
3.1 Durvalumab Sales by Manufacturers
3.1.1 Durvalumab Sales by Manufacturers (2015-2020)
3.1.2 Durvalumab Sales Market Share by Manufacturers (2015-2020)
3.2 Durvalumab Revenue by Manufacturers
3.2.1 Durvalumab Revenue by Manufacturers (2015-2020)
3.2.2 Durvalumab Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Durvalumab Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Durvalumab Revenue in 2019
3.2.5 Global Durvalumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Durvalumab Price by Manufacturers
3.4 Durvalumab Manufacturing Base Distribution, Product Types
3.4.1 Durvalumab Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Durvalumab Product Type
3.4.3 Date of International Manufacturers Enter into Durvalumab Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Durvalumab Market Size by Type (2015-2020)
4.1.1 Global Durvalumab Sales by Type (2015-2020)
4.1.2 Global Durvalumab Revenue by Type (2015-2020)
4.1.3 Durvalumab Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Durvalumab Market Size Forecast by Type (2021-2026)
4.2.1 Global Durvalumab Sales Forecast by Type (2021-2026)
4.2.2 Global Durvalumab Revenue Forecast by Type (2021-2026)
4.2.3 Durvalumab Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Durvalumab Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Durvalumab Market Size by Application (2015-2020)
5.1.1 Global Durvalumab Sales by Application (2015-2020)
5.1.2 Global Durvalumab Revenue by Application (2015-2020)
5.1.3 Durvalumab Price by Application (2015-2020)
5.2 Durvalumab Market Size Forecast by Application (2021-2026)
5.2.1 Global Durvalumab Sales Forecast by Application (2021-2026)
5.2.2 Global Durvalumab Revenue Forecast by Application (2021-2026)
5.2.3 Global Durvalumab Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Durvalumab by Country
6.1.1 North America Durvalumab Sales by Country
6.1.2 North America Durvalumab Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Durvalumab Market Facts & Figures by Type
6.3 North America Durvalumab Market Facts & Figures by Application
7 EUROPE
7.1 Europe Durvalumab by Country
7.1.1 Europe Durvalumab Sales by Country
7.1.2 Europe Durvalumab Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Durvalumab Market Facts & Figures by Type
7.3 Europe Durvalumab Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Durvalumab by Region
8.1.1 Asia Pacific Durvalumab Sales by Region
8.1.2 Asia Pacific Durvalumab Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Durvalumab Market Facts & Figures by Type
8.3 Asia Pacific Durvalumab Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Durvalumab by Country
9.1.1 Latin America Durvalumab Sales by Country
9.1.2 Latin America Durvalumab Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Durvalumab Market Facts & Figures by Type
9.3 Central & South America Durvalumab Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Durvalumab by Country
10.1.1 Middle East and Africa Durvalumab Sales by Country
10.1.2 Middle East and Africa Durvalumab Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Durvalumab Market Facts & Figures by Type
10.3 Middle East and Africa Durvalumab Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Medimmune (AstraZeneca)
11.1.1 Medimmune (AstraZeneca) Corporation Information
11.1.2 Medimmune (AstraZeneca) Description, Business Overview and Total Revenue
11.1.3 Medimmune (AstraZeneca) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Medimmune (AstraZeneca) Durvalumab Products Offered
11.1.5 Medimmune (AstraZeneca) Recent Development
11.1 Medimmune (AstraZeneca)
11.1.1 Medimmune (AstraZeneca) Corporation Information
11.1.2 Medimmune (AstraZeneca) Description, Business Overview and Total Revenue
11.1.3 Medimmune (AstraZeneca) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Medimmune (AstraZeneca) Durvalumab Products Offered
11.1.5 Medimmune (AstraZeneca) Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Durvalumab Market Estimates and Projections by Region
12.1.1 Global Durvalumab Sales Forecast by Regions 2021-2026
12.1.2 Global Durvalumab Revenue Forecast by Regions 2021-2026
12.2 North America Durvalumab Market Size Forecast (2021-2026)
12.2.1 North America: Durvalumab Sales Forecast (2021-2026)
12.2.2 North America: Durvalumab Revenue Forecast (2021-2026)
12.2.3 North America: Durvalumab Market Size Forecast by Country (2021-2026)
12.3 Europe Durvalumab Market Size Forecast (2021-2026)
12.3.1 Europe: Durvalumab Sales Forecast (2021-2026)
12.3.2 Europe: Durvalumab Revenue Forecast (2021-2026)
12.3.3 Europe: Durvalumab Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Durvalumab Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Durvalumab Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Durvalumab Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Durvalumab Market Size Forecast by Region (2021-2026)
12.5 Latin America Durvalumab Market Size Forecast (2021-2026)
12.5.1 Latin America: Durvalumab Sales Forecast (2021-2026)
12.5.2 Latin America: Durvalumab Revenue Forecast (2021-2026)
12.5.3 Latin America: Durvalumab Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Durvalumab Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Durvalumab Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Durvalumab Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Durvalumab Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Durvalumab Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Durvalumab Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Durvalumab Product Introduction
1.2 Market Segments
1.3 Key Durvalumab Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Durvalumab Market Size Growth Rate by Type
1.4.2 2.4mL Injection
1.4.3 10mL Injection
1.5 Market by Application
1.5.1 Global Durvalumab Market Size Growth Rate by Application
1.5.2 Locally Advanced Urothelial Carcinoma
1.5.3 Metastatic Urothelial Carcinoma
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Durvalumab Industry Impact
1.6.1 How the Covid-19 is Affecting the Durvalumab Industry
1.6.1.1 Durvalumab Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Durvalumab Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Durvalumab Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Durvalumab Market Size Estimates and Forecasts
2.1.1 Global Durvalumab Revenue 2015-2026
2.1.2 Global Durvalumab Sales 2015-2026
2.2 Durvalumab Market Size by Region: 2020 Versus 2026
2.2.1 Global Durvalumab Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Durvalumab Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL DURVALUMAB COMPETITOR LANDSCAPE BY PLAYERS
3.1 Durvalumab Sales by Manufacturers
3.1.1 Durvalumab Sales by Manufacturers (2015-2020)
3.1.2 Durvalumab Sales Market Share by Manufacturers (2015-2020)
3.2 Durvalumab Revenue by Manufacturers
3.2.1 Durvalumab Revenue by Manufacturers (2015-2020)
3.2.2 Durvalumab Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Durvalumab Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Durvalumab Revenue in 2019
3.2.5 Global Durvalumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Durvalumab Price by Manufacturers
3.4 Durvalumab Manufacturing Base Distribution, Product Types
3.4.1 Durvalumab Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Durvalumab Product Type
3.4.3 Date of International Manufacturers Enter into Durvalumab Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Durvalumab Market Size by Type (2015-2020)
4.1.1 Global Durvalumab Sales by Type (2015-2020)
4.1.2 Global Durvalumab Revenue by Type (2015-2020)
4.1.3 Durvalumab Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Durvalumab Market Size Forecast by Type (2021-2026)
4.2.1 Global Durvalumab Sales Forecast by Type (2021-2026)
4.2.2 Global Durvalumab Revenue Forecast by Type (2021-2026)
4.2.3 Durvalumab Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Durvalumab Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Durvalumab Market Size by Application (2015-2020)
5.1.1 Global Durvalumab Sales by Application (2015-2020)
5.1.2 Global Durvalumab Revenue by Application (2015-2020)
5.1.3 Durvalumab Price by Application (2015-2020)
5.2 Durvalumab Market Size Forecast by Application (2021-2026)
5.2.1 Global Durvalumab Sales Forecast by Application (2021-2026)
5.2.2 Global Durvalumab Revenue Forecast by Application (2021-2026)
5.2.3 Global Durvalumab Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Durvalumab by Country
6.1.1 North America Durvalumab Sales by Country
6.1.2 North America Durvalumab Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Durvalumab Market Facts & Figures by Type
6.3 North America Durvalumab Market Facts & Figures by Application
7 EUROPE
7.1 Europe Durvalumab by Country
7.1.1 Europe Durvalumab Sales by Country
7.1.2 Europe Durvalumab Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Durvalumab Market Facts & Figures by Type
7.3 Europe Durvalumab Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Durvalumab by Region
8.1.1 Asia Pacific Durvalumab Sales by Region
8.1.2 Asia Pacific Durvalumab Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Durvalumab Market Facts & Figures by Type
8.3 Asia Pacific Durvalumab Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Durvalumab by Country
9.1.1 Latin America Durvalumab Sales by Country
9.1.2 Latin America Durvalumab Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Durvalumab Market Facts & Figures by Type
9.3 Central & South America Durvalumab Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Durvalumab by Country
10.1.1 Middle East and Africa Durvalumab Sales by Country
10.1.2 Middle East and Africa Durvalumab Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Durvalumab Market Facts & Figures by Type
10.3 Middle East and Africa Durvalumab Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Medimmune (AstraZeneca)
11.1.1 Medimmune (AstraZeneca) Corporation Information
11.1.2 Medimmune (AstraZeneca) Description, Business Overview and Total Revenue
11.1.3 Medimmune (AstraZeneca) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Medimmune (AstraZeneca) Durvalumab Products Offered
11.1.5 Medimmune (AstraZeneca) Recent Development
11.1 Medimmune (AstraZeneca)
11.1.1 Medimmune (AstraZeneca) Corporation Information
11.1.2 Medimmune (AstraZeneca) Description, Business Overview and Total Revenue
11.1.3 Medimmune (AstraZeneca) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Medimmune (AstraZeneca) Durvalumab Products Offered
11.1.5 Medimmune (AstraZeneca) Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Durvalumab Market Estimates and Projections by Region
12.1.1 Global Durvalumab Sales Forecast by Regions 2021-2026
12.1.2 Global Durvalumab Revenue Forecast by Regions 2021-2026
12.2 North America Durvalumab Market Size Forecast (2021-2026)
12.2.1 North America: Durvalumab Sales Forecast (2021-2026)
12.2.2 North America: Durvalumab Revenue Forecast (2021-2026)
12.2.3 North America: Durvalumab Market Size Forecast by Country (2021-2026)
12.3 Europe Durvalumab Market Size Forecast (2021-2026)
12.3.1 Europe: Durvalumab Sales Forecast (2021-2026)
12.3.2 Europe: Durvalumab Revenue Forecast (2021-2026)
12.3.3 Europe: Durvalumab Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Durvalumab Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Durvalumab Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Durvalumab Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Durvalumab Market Size Forecast by Region (2021-2026)
12.5 Latin America Durvalumab Market Size Forecast (2021-2026)
12.5.1 Latin America: Durvalumab Sales Forecast (2021-2026)
12.5.2 Latin America: Durvalumab Revenue Forecast (2021-2026)
12.5.3 Latin America: Durvalumab Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Durvalumab Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Durvalumab Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Durvalumab Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Durvalumab Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Durvalumab Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Durvalumab Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Durvalumab Market Segments
Table 2. Ranking of Global Top Durvalumab Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Durvalumab Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of 2.4mL Injection
Table 5. Major Manufacturers of 10mL Injection
Table 6. COVID-19 Impact Global Market: (Four Durvalumab Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Durvalumab Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Durvalumab Players to Combat Covid-19 Impact
Table 11. Global Durvalumab Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 12. Global Durvalumab Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 13. Global Durvalumab Sales by Regions 2015-2020 (K Pcs)
Table 14. Global Durvalumab Sales Market Share by Regions (2015-2020)
Table 15. Global Durvalumab Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Durvalumab Sales by Manufacturers (2015-2020) (K Pcs)
Table 17. Global Durvalumab Sales Share by Manufacturers (2015-2020)
Table 18. Global Durvalumab Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Durvalumab by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Durvalumab as of 2019)
Table 20. Durvalumab Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Durvalumab Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Durvalumab Price (2015-2020) (USD/Pcs)
Table 23. Durvalumab Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Durvalumab Product Type
Table 25. Date of International Manufacturers Enter into Durvalumab Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Durvalumab Sales by Type (2015-2020) (K Pcs)
Table 28. Global Durvalumab Sales Share by Type (2015-2020)
Table 29. Global Durvalumab Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Durvalumab Revenue Share by Type (2015-2020)
Table 31. Durvalumab Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 32. Global Durvalumab Sales by Application (2015-2020) (K Pcs)
Table 33. Global Durvalumab Sales Share by Application (2015-2020)
Table 34. North America Durvalumab Sales by Country (2015-2020) (K Pcs)
Table 35. North America Durvalumab Sales Market Share by Country (2015-2020)
Table 36. North America Durvalumab Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Durvalumab Revenue Market Share by Country (2015-2020)
Table 38. North America Durvalumab Sales by Type (2015-2020) (K Pcs)
Table 39. North America Durvalumab Sales Market Share by Type (2015-2020)
Table 40. North America Durvalumab Sales by Application (2015-2020) (K Pcs)
Table 41. North America Durvalumab Sales Market Share by Application (2015-2020)
Table 42. Europe Durvalumab Sales by Country (2015-2020) (K Pcs)
Table 43. Europe Durvalumab Sales Market Share by Country (2015-2020)
Table 44. Europe Durvalumab Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Durvalumab Revenue Market Share by Country (2015-2020)
Table 46. Europe Durvalumab Sales by Type (2015-2020) (K Pcs)
Table 47. Europe Durvalumab Sales Market Share by Type (2015-2020)
Table 48. Europe Durvalumab Sales by Application (2015-2020) (K Pcs)
Table 49. Europe Durvalumab Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Durvalumab Sales by Region (2015-2020) (K Pcs)
Table 51. Asia Pacific Durvalumab Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Durvalumab Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Durvalumab Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Durvalumab Sales by Type (2015-2020) (K Pcs)
Table 55. Asia Pacific Durvalumab Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Durvalumab Sales by Application (2015-2020) (K Pcs)
Table 57. Asia Pacific Durvalumab Sales Market Share by Application (2015-2020)
Table 58. Latin America Durvalumab Sales by Country (2015-2020) (K Pcs)
Table 59. Latin America Durvalumab Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Durvalumab Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Durvalumab Revenue Market Share by Country (2015-2020)
Table 62. Latin America Durvalumab Sales by Type (2015-2020) (K Pcs)
Table 63. Latin America Durvalumab Sales Market Share by Type (2015-2020)
Table 64. Latin America Durvalumab Sales by Application (2015-2020) (K Pcs)
Table 65. Latin America Durvalumab Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Durvalumab Sales by Country (2015-2020) (K Pcs)
Table 67. Middle East and Africa Durvalumab Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Durvalumab Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Durvalumab Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Durvalumab Sales by Type (2015-2020) (K Pcs)
Table 71. Middle East and Africa Durvalumab Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Durvalumab Sales by Application (2015-2020) (K Pcs)
Table 73. Middle East and Africa Durvalumab Sales Market Share by Application (2015-2020)
Table 74. Medimmune (AstraZeneca) Corporation Information
Table 75. Medimmune (AstraZeneca) Description and Major Businesses
Table 76. Medimmune (AstraZeneca) Durvalumab Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 77. Medimmune (AstraZeneca) Product
Table 78. Medimmune (AstraZeneca) Recent Development
Table 79. Global Durvalumab Sales Forecast by Regions (2021-2026) (K Pcs)
Table 80. Global Durvalumab Sales Market Share Forecast by Regions (2021-2026)
Table 81. Global Durvalumab Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 82. Global Durvalumab Revenue Market Share Forecast by Regions (2021-2026)
Table 83. North America: Durvalumab Sales Forecast by Country (2021-2026) (K Pcs)
Table 84. North America: Durvalumab Revenue Forecast by Country (2021-2026) (US$ Million)
Table 85. Europe: Durvalumab Sales Forecast by Country (2021-2026) (K Pcs)
Table 86. Europe: Durvalumab Revenue Forecast by Country (2021-2026) (US$ Million)
Table 87. Asia Pacific: Durvalumab Sales Forecast by Region (2021-2026) (K Pcs)
Table 88. Asia Pacific: Durvalumab Revenue Forecast by Region (2021-2026) (US$ Million)
Table 89. Latin America: Durvalumab Sales Forecast by Country (2021-2026) (K Pcs)
Table 90. Latin America: Durvalumab Revenue Forecast by Country (2021-2026) (US$ Million)
Table 91. Middle East and Africa: Durvalumab Sales Forecast by Country (2021-2026) (K Pcs)
Table 92. Middle East and Africa: Durvalumab Revenue Forecast by Country (2021-2026) (US$ Million)
Table 93. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 94. Key Challenges
Table 95. Market Risks
Table 96. Main Points Interviewed from Key Durvalumab Players
Table 97. Durvalumab Customers List
Table 98. Durvalumab Distributors List
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
Table 1. Durvalumab Market Segments
Table 2. Ranking of Global Top Durvalumab Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Durvalumab Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of 2.4mL Injection
Table 5. Major Manufacturers of 10mL Injection
Table 6. COVID-19 Impact Global Market: (Four Durvalumab Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Durvalumab Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Durvalumab Players to Combat Covid-19 Impact
Table 11. Global Durvalumab Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 12. Global Durvalumab Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 13. Global Durvalumab Sales by Regions 2015-2020 (K Pcs)
Table 14. Global Durvalumab Sales Market Share by Regions (2015-2020)
Table 15. Global Durvalumab Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Durvalumab Sales by Manufacturers (2015-2020) (K Pcs)
Table 17. Global Durvalumab Sales Share by Manufacturers (2015-2020)
Table 18. Global Durvalumab Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Durvalumab by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Durvalumab as of 2019)
Table 20. Durvalumab Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Durvalumab Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Durvalumab Price (2015-2020) (USD/Pcs)
Table 23. Durvalumab Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Durvalumab Product Type
Table 25. Date of International Manufacturers Enter into Durvalumab Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Durvalumab Sales by Type (2015-2020) (K Pcs)
Table 28. Global Durvalumab Sales Share by Type (2015-2020)
Table 29. Global Durvalumab Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Durvalumab Revenue Share by Type (2015-2020)
Table 31. Durvalumab Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 32. Global Durvalumab Sales by Application (2015-2020) (K Pcs)
Table 33. Global Durvalumab Sales Share by Application (2015-2020)
Table 34. North America Durvalumab Sales by Country (2015-2020) (K Pcs)
Table 35. North America Durvalumab Sales Market Share by Country (2015-2020)
Table 36. North America Durvalumab Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Durvalumab Revenue Market Share by Country (2015-2020)
Table 38. North America Durvalumab Sales by Type (2015-2020) (K Pcs)
Table 39. North America Durvalumab Sales Market Share by Type (2015-2020)
Table 40. North America Durvalumab Sales by Application (2015-2020) (K Pcs)
Table 41. North America Durvalumab Sales Market Share by Application (2015-2020)
Table 42. Europe Durvalumab Sales by Country (2015-2020) (K Pcs)
Table 43. Europe Durvalumab Sales Market Share by Country (2015-2020)
Table 44. Europe Durvalumab Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Durvalumab Revenue Market Share by Country (2015-2020)
Table 46. Europe Durvalumab Sales by Type (2015-2020) (K Pcs)
Table 47. Europe Durvalumab Sales Market Share by Type (2015-2020)
Table 48. Europe Durvalumab Sales by Application (2015-2020) (K Pcs)
Table 49. Europe Durvalumab Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Durvalumab Sales by Region (2015-2020) (K Pcs)
Table 51. Asia Pacific Durvalumab Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Durvalumab Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Durvalumab Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Durvalumab Sales by Type (2015-2020) (K Pcs)
Table 55. Asia Pacific Durvalumab Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Durvalumab Sales by Application (2015-2020) (K Pcs)
Table 57. Asia Pacific Durvalumab Sales Market Share by Application (2015-2020)
Table 58. Latin America Durvalumab Sales by Country (2015-2020) (K Pcs)
Table 59. Latin America Durvalumab Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Durvalumab Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Durvalumab Revenue Market Share by Country (2015-2020)
Table 62. Latin America Durvalumab Sales by Type (2015-2020) (K Pcs)
Table 63. Latin America Durvalumab Sales Market Share by Type (2015-2020)
Table 64. Latin America Durvalumab Sales by Application (2015-2020) (K Pcs)
Table 65. Latin America Durvalumab Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Durvalumab Sales by Country (2015-2020) (K Pcs)
Table 67. Middle East and Africa Durvalumab Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Durvalumab Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Durvalumab Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Durvalumab Sales by Type (2015-2020) (K Pcs)
Table 71. Middle East and Africa Durvalumab Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Durvalumab Sales by Application (2015-2020) (K Pcs)
Table 73. Middle East and Africa Durvalumab Sales Market Share by Application (2015-2020)
Table 74. Medimmune (AstraZeneca) Corporation Information
Table 75. Medimmune (AstraZeneca) Description and Major Businesses
Table 76. Medimmune (AstraZeneca) Durvalumab Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 77. Medimmune (AstraZeneca) Product
Table 78. Medimmune (AstraZeneca) Recent Development
Table 79. Global Durvalumab Sales Forecast by Regions (2021-2026) (K Pcs)
Table 80. Global Durvalumab Sales Market Share Forecast by Regions (2021-2026)
Table 81. Global Durvalumab Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 82. Global Durvalumab Revenue Market Share Forecast by Regions (2021-2026)
Table 83. North America: Durvalumab Sales Forecast by Country (2021-2026) (K Pcs)
Table 84. North America: Durvalumab Revenue Forecast by Country (2021-2026) (US$ Million)
Table 85. Europe: Durvalumab Sales Forecast by Country (2021-2026) (K Pcs)
Table 86. Europe: Durvalumab Revenue Forecast by Country (2021-2026) (US$ Million)
Table 87. Asia Pacific: Durvalumab Sales Forecast by Region (2021-2026) (K Pcs)
Table 88. Asia Pacific: Durvalumab Revenue Forecast by Region (2021-2026) (US$ Million)
Table 89. Latin America: Durvalumab Sales Forecast by Country (2021-2026) (K Pcs)
Table 90. Latin America: Durvalumab Revenue Forecast by Country (2021-2026) (US$ Million)
Table 91. Middle East and Africa: Durvalumab Sales Forecast by Country (2021-2026) (K Pcs)
Table 92. Middle East and Africa: Durvalumab Revenue Forecast by Country (2021-2026) (US$ Million)
Table 93. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 94. Key Challenges
Table 95. Market Risks
Table 96. Main Points Interviewed from Key Durvalumab Players
Table 97. Durvalumab Customers List
Table 98. Durvalumab Distributors List
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Durvalumab Product Picture
Figure 2. Global Durvalumab Sales Market Share by Type in 2020 & 2026
Figure 3. 2.4mL Injection Product Picture
Figure 4. 10mL Injection Product Picture
Figure 5. Global Durvalumab Sales Market Share by Application in 2020 & 2026
Figure 6. Locally Advanced Urothelial Carcinoma
Figure 7. Metastatic Urothelial Carcinoma
Figure 8. Other
Figure 9. Durvalumab Report Years Considered
Figure 10. Global Durvalumab Market Size 2015-2026 (US$ Million)
Figure 11. Global Durvalumab Sales 2015-2026 (K Pcs)
Figure 12. Global Durvalumab Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Durvalumab Sales Market Share by Region (2015-2020)
Figure 14. Global Durvalumab Sales Market Share by Region in 2019
Figure 15. Global Durvalumab Revenue Market Share by Region (2015-2020)
Figure 16. Global Durvalumab Revenue Market Share by Region in 2019
Figure 17. Global Durvalumab Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Durvalumab Revenue in 2019
Figure 19. Durvalumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Durvalumab Sales Market Share by Type (2015-2020)
Figure 21. Global Durvalumab Sales Market Share by Type in 2019
Figure 22. Global Durvalumab Revenue Market Share by Type (2015-2020)
Figure 23. Global Durvalumab Revenue Market Share by Type in 2019
Figure 24. Global Durvalumab Market Share by Price Range (2015-2020)
Figure 25. Global Durvalumab Sales Market Share by Application (2015-2020)
Figure 26. Global Durvalumab Sales Market Share by Application in 2019
Figure 27. Global Durvalumab Revenue Market Share by Application (2015-2020)
Figure 28. Global Durvalumab Revenue Market Share by Application in 2019
Figure 29. North America Durvalumab Sales Growth Rate 2015-2020 (K Pcs)
Figure 30. North America Durvalumab Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Durvalumab Sales Market Share by Country in 2019
Figure 32. North America Durvalumab Revenue Market Share by Country in 2019
Figure 33. U.S. Durvalumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 34. U.S. Durvalumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Durvalumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 36. Canada Durvalumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Durvalumab Market Share by Type in 2019
Figure 38. North America Durvalumab Market Share by Application in 2019
Figure 39. Europe Durvalumab Sales Growth Rate 2015-2020 (K Pcs)
Figure 40. Europe Durvalumab Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Durvalumab Sales Market Share by Country in 2019
Figure 42. Europe Durvalumab Revenue Market Share by Country in 2019
Figure 43. Germany Durvalumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 44. Germany Durvalumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Durvalumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. France Durvalumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Durvalumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. U.K. Durvalumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Durvalumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. Italy Durvalumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Durvalumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. Russia Durvalumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Durvalumab Market Share by Type in 2019
Figure 54. Europe Durvalumab Market Share by Application in 2019
Figure 55. Asia Pacific Durvalumab Sales Growth Rate 2015-2020 (K Pcs)
Figure 56. Asia Pacific Durvalumab Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Durvalumab Sales Market Share by Region in 2019
Figure 58. Asia Pacific Durvalumab Revenue Market Share by Region in 2019
Figure 59. China Durvalumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 60. China Durvalumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Durvalumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 62. Japan Durvalumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Durvalumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. South Korea Durvalumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Durvalumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. India Durvalumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Durvalumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. Australia Durvalumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Durvalumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. Taiwan Durvalumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Durvalumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Indonesia Durvalumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Durvalumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Thailand Durvalumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Durvalumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Malaysia Durvalumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Durvalumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Philippines Durvalumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Durvalumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Vietnam Durvalumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Durvalumab Market Share by Type in 2019
Figure 82. Asia Pacific Durvalumab Market Share by Application in 2019
Figure 83. Latin America Durvalumab Sales Growth Rate 2015-2020 (K Pcs)
Figure 84. Latin America Durvalumab Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Durvalumab Sales Market Share by Country in 2019
Figure 86. Latin America Durvalumab Revenue Market Share by Country in 2019
Figure 87. Mexico Durvalumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 88. Mexico Durvalumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Durvalumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 90. Brazil Durvalumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Durvalumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Argentina Durvalumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Durvalumab Market Share by Type in 2019
Figure 94. Latin America Durvalumab Market Share by Application in 2019
Figure 95. Middle East and Africa Durvalumab Sales Growth Rate 2015-2020 (K Pcs)
Figure 96. Middle East and Africa Durvalumab Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Durvalumab Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Durvalumab Revenue Market Share by Country in 2019
Figure 99. Turkey Durvalumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 100. Turkey Durvalumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Durvalumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 102. Saudi Arabia Durvalumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Durvalumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. U.A.E Durvalumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Durvalumab Market Share by Type in 2019
Figure 106. Middle East and Africa Durvalumab Market Share by Application in 2019
Figure 107. Medimmune (AstraZeneca) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. North America Durvalumab Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 109. North America Durvalumab Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Durvalumab Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. Europe Durvalumab Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Durvalumab Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Asia Pacific Durvalumab Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Durvalumab Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Latin America Durvalumab Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Durvalumab Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Middle East and Africa Durvalumab Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
Figure 1. Durvalumab Product Picture
Figure 2. Global Durvalumab Sales Market Share by Type in 2020 & 2026
Figure 3. 2.4mL Injection Product Picture
Figure 4. 10mL Injection Product Picture
Figure 5. Global Durvalumab Sales Market Share by Application in 2020 & 2026
Figure 6. Locally Advanced Urothelial Carcinoma
Figure 7. Metastatic Urothelial Carcinoma
Figure 8. Other
Figure 9. Durvalumab Report Years Considered
Figure 10. Global Durvalumab Market Size 2015-2026 (US$ Million)
Figure 11. Global Durvalumab Sales 2015-2026 (K Pcs)
Figure 12. Global Durvalumab Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Durvalumab Sales Market Share by Region (2015-2020)
Figure 14. Global Durvalumab Sales Market Share by Region in 2019
Figure 15. Global Durvalumab Revenue Market Share by Region (2015-2020)
Figure 16. Global Durvalumab Revenue Market Share by Region in 2019
Figure 17. Global Durvalumab Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Durvalumab Revenue in 2019
Figure 19. Durvalumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Durvalumab Sales Market Share by Type (2015-2020)
Figure 21. Global Durvalumab Sales Market Share by Type in 2019
Figure 22. Global Durvalumab Revenue Market Share by Type (2015-2020)
Figure 23. Global Durvalumab Revenue Market Share by Type in 2019
Figure 24. Global Durvalumab Market Share by Price Range (2015-2020)
Figure 25. Global Durvalumab Sales Market Share by Application (2015-2020)
Figure 26. Global Durvalumab Sales Market Share by Application in 2019
Figure 27. Global Durvalumab Revenue Market Share by Application (2015-2020)
Figure 28. Global Durvalumab Revenue Market Share by Application in 2019
Figure 29. North America Durvalumab Sales Growth Rate 2015-2020 (K Pcs)
Figure 30. North America Durvalumab Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Durvalumab Sales Market Share by Country in 2019
Figure 32. North America Durvalumab Revenue Market Share by Country in 2019
Figure 33. U.S. Durvalumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 34. U.S. Durvalumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Durvalumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 36. Canada Durvalumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Durvalumab Market Share by Type in 2019
Figure 38. North America Durvalumab Market Share by Application in 2019
Figure 39. Europe Durvalumab Sales Growth Rate 2015-2020 (K Pcs)
Figure 40. Europe Durvalumab Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Durvalumab Sales Market Share by Country in 2019
Figure 42. Europe Durvalumab Revenue Market Share by Country in 2019
Figure 43. Germany Durvalumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 44. Germany Durvalumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Durvalumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. France Durvalumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Durvalumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. U.K. Durvalumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Durvalumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. Italy Durvalumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Durvalumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. Russia Durvalumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Durvalumab Market Share by Type in 2019
Figure 54. Europe Durvalumab Market Share by Application in 2019
Figure 55. Asia Pacific Durvalumab Sales Growth Rate 2015-2020 (K Pcs)
Figure 56. Asia Pacific Durvalumab Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Durvalumab Sales Market Share by Region in 2019
Figure 58. Asia Pacific Durvalumab Revenue Market Share by Region in 2019
Figure 59. China Durvalumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 60. China Durvalumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Durvalumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 62. Japan Durvalumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Durvalumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. South Korea Durvalumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Durvalumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. India Durvalumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Durvalumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. Australia Durvalumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Durvalumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. Taiwan Durvalumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Durvalumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Indonesia Durvalumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Durvalumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Thailand Durvalumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Durvalumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Malaysia Durvalumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Durvalumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Philippines Durvalumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Durvalumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Vietnam Durvalumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Durvalumab Market Share by Type in 2019
Figure 82. Asia Pacific Durvalumab Market Share by Application in 2019
Figure 83. Latin America Durvalumab Sales Growth Rate 2015-2020 (K Pcs)
Figure 84. Latin America Durvalumab Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Durvalumab Sales Market Share by Country in 2019
Figure 86. Latin America Durvalumab Revenue Market Share by Country in 2019
Figure 87. Mexico Durvalumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 88. Mexico Durvalumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Durvalumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 90. Brazil Durvalumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Durvalumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Argentina Durvalumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Durvalumab Market Share by Type in 2019
Figure 94. Latin America Durvalumab Market Share by Application in 2019
Figure 95. Middle East and Africa Durvalumab Sales Growth Rate 2015-2020 (K Pcs)
Figure 96. Middle East and Africa Durvalumab Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Durvalumab Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Durvalumab Revenue Market Share by Country in 2019
Figure 99. Turkey Durvalumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 100. Turkey Durvalumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Durvalumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 102. Saudi Arabia Durvalumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Durvalumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. U.A.E Durvalumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Durvalumab Market Share by Type in 2019
Figure 106. Middle East and Africa Durvalumab Market Share by Application in 2019
Figure 107. Medimmune (AstraZeneca) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. North America Durvalumab Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 109. North America Durvalumab Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Durvalumab Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. Europe Durvalumab Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Durvalumab Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Asia Pacific Durvalumab Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Durvalumab Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Latin America Durvalumab Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Durvalumab Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Middle East and Africa Durvalumab Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
